Goldman Sachs
Healthcare
Goldman Sachs-backed Aragen Life Sciences weighs IPO, in talks with bankers
Aragen Life Sciences Ltd, a contract drug development and manufacturing company backed by private equity funds managed by Goldman Sachs, ......
Consumer
Haier's India arm draws interest from more local strategic players, foreign funds
Chinese household appliances maker Haier Smart Home Co.’s Indian unit has attracted interest from local strategic players as well as ......
General
Grapevine: Boat, Zomato, Brookfield, Porter, Piramal-Bain ARC, Oyo, MPL in news
Gentari Sdn Bhd has agreed to acquire a renewables portfolio from Brookfield Asset Management, while Zomato has enlisted Morgan Stanley, ......
General
Grapevine: Jubilant Group, Goldman Sachs, HDFC, Zetwerk, and LG Electronics in news
The Bhartia family is in talks with a marquee investment bank to jointly acquire stake in Hindustan Coca-Cola Beverages, while ......
Finance
Saudi Arabian wealth fund PIF to cut overseas investments
Saudi Arabia's sovereign wealth fund plans to cut its overseas investments by about a third, its governor told a conference ......
TMT
Softbank-backed ElasticRun trims loss as focus on regional brands improves margins
Business-to-business e-commerce platform ElasticRun cut its losses by about half in the financial year ended March 2024, as a shift ......
Finance
Why global LPs are looking to increase private credit allocations
Despite the current under-allocation towards private credit strategies, limited partners globally are considering raising their exposure to this asset class ......
Finance
Goldman Sachs' Saudi Arabia CEO leaving firm
Goldman Sachs' Saudi Arabia CEO, Khalid Albdah, is leaving the firm, a source familiar with the situation told Reuters on Wednesday. Albdah has been ......
Consumer
ADIA-backed Purplle closes Series F at $178 mn, Sharrp Ventures joins cap table
Omnichannel beauty platform Purplle Monday said it has closed its Series F funding round, having raised Rs 1,500 crore (around ......
General
Grapevine: Aragen Life, Urban Company investors weigh stake sale
Promoters and investors in Aragen Life Sciences, the Goldman Sachs-backed contract research organisation (CRO), plan to sell a 10% stake in a ......